Feature Head to head

Should young people be given antidepressants? Yes

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39316.399931.94 (Published 11 October 2007) Cite this as: BMJ 2007;335:750
  1. Andrew Cotgrove, clinical director
  1. Pine Lodge Young People's Centre, Cheshire and Wirral Partnership NHS Foundation Trust, Chester CH2 1AW
  1. andy.cotgrove{at}cwpnt.nhs.uk

    Depression is disabling a growing proportion of children, but evidence on treatment is disputed. Andrew Cotgrove believes drugs are a vital part of the armoury but Sami Timimi is unconvinced that they are helpful or safe

    Depression and obsessive-compulsive disorder cause considerable distress in young people. These disorders affect emotional, educational, and social development. To deny these vulnerable groups the possibility of receiving antidepressants would be to withhold one of the few evidence based treatments available to them.

    There are genuine reasons to question their use. Firstly, much of the evidence has, quite rightly, been strongly criticised in recent years. Secondly, the drugs are associated with appreciable risks, in particular an increase in suicidality. Thirdly, other treatments are available. Nevertheless, the evidence indicates that the benefits of these drugs outweigh the risks when used in the appropriate clinical context. I shall focus on the use of selective serotonin reuptake inhibitors (SSRIs) because this is the group of antidepressants for which the evidence in young people is strongest1 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe